These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16915023)

  • 21. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.
    Diabetes; 1997 Nov; 46(11):1829-39. PubMed ID: 9356033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of metabolic control and duration on exercise-induced albuminuria in diabetic teen-agers.
    Dahlquist G; Aperia A; Carlsson L; Linné T; Persson B; Thorén C; Wilton P
    Acta Paediatr Scand; 1983 Nov; 72(6):895-902. PubMed ID: 6369869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal involvement in type 1 (IDDM) diabetes in Spain. ESTUDIO DIAMANTE.
    Diabetes Res Clin Pract; 1997 Nov; 38(2):129-37. PubMed ID: 9483377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy.
    Friedman AN; Hunsicker LG; Selhub J; Bostom AG
    Atherosclerosis; 2004 Jan; 172(1):121-5. PubMed ID: 14709365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of clinical and biochemical variables in type 2 diabetes mellitus patients and their first-degree relatives with metabolic syndrome in Benin City, Nigeria: A cross sectional case controlled study.
    Ogedengbe S; Ezeani IU; Aihanuwa E
    Endocr Regul; 2016 Jan; 50(1):32-40. PubMed ID: 27560635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with type 1 (insulin-dependent) diabetes mellitus.
    Winocour PH; Durrington PN; Bhatnagar D; Mbewu AD; Ishola M; Mackness M; Arrol S
    Diabetes Res Clin Pract; 1992 Dec; 18(3):173-84. PubMed ID: 1289018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation].
    Jungmann E; Carlberg C; Schallmayer M; Schumm-Draeger PM
    Med Klin (Munich); 1995 Jul; 90(7):383-9. PubMed ID: 7675002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patients.
    Rasmussen LM; Tarnow L; Hansen TK; Parving HH; Flyvbjerg A
    Eur J Endocrinol; 2006 Jan; 154(1):75-81. PubMed ID: 16381994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of Irisin Hormone Level in Type 2 Diabetic Patients and Patients with Diabetic Nephropathy.
    Shelbaya S; Abu Shady MM; Nasr MS; Bekhet MM; Mageed YA; Abbas M
    Curr Diabetes Rev; 2018; 14(5):481-486. PubMed ID: 28875825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher blood pressure in normoalbuminuric type 1 diabetic patients with a familial history of type 2 diabetes.
    Damci T; Osar Z; Ilkova H
    Diabetes Metab; 2002 Nov; 28(5):417-20. PubMed ID: 12461481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy.
    Yokoyama H; Jensen JS; Jensen T; Deckert T
    J Intern Med; 1995 May; 237(5):519-23. PubMed ID: 7738493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microvascular complications and risk factors in patients with type 2 diabetes.
    Del Cañizo Gómez FJ; Fernández Pérez C; Moreno Ruiz I; de Gorospe Pérez-Jáuregui C; Silveira Rodríguez B; González Losada T; Segura Galindo A
    Endocrinol Nutr; 2011 Apr; 58(4):163-8. PubMed ID: 21411384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes?
    Osei K; Rhinesmith S; Gaillard T; Schuster D
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4596-601. PubMed ID: 14557428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus.
    Wiseman M; Viberti G; Mackintosh D; Jarrett RJ; Keen H
    Diabetologia; 1984 Jun; 26(6):401-5. PubMed ID: 6468790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A low-cost laboratory-based method for predicting newly diagnosed biopsy-proven diabetic nephropathy in people with type 2 diabetes.
    Yu D; Shang J; Cai Y; Wang Z; Zhao B; Zhao Z; Simmons D
    Diabet Med; 2020 Oct; 37(10):1728-1736. PubMed ID: 31797436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycaemic control influences the relationship between plasma PCSK9 and LDL cholesterol in type 1 diabetes.
    Laugier-Robiolle S; Vergès B; Le Bras M; Gand E; Bouillet B; Saulnier PJ; Le May C; Pichelin M; Maréchaud R; Petit JM; Hadjadj S; Cariou B
    Diabetes Obes Metab; 2017 Mar; 19(3):448-451. PubMed ID: 27804190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of vitamin D, obesity and physical exercise in regulation of glycemia in Type 2 Diabetes Mellitus patients.
    Bener A; Al-Hamaq AO; Kurtulus EM; Abdullatef WK; Zirie M
    Diabetes Metab Syndr; 2016; 10(4):198-204. PubMed ID: 27381964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The metabolic syndrome in patients with type 1 diabetes mellitus. Associations with cardiovascular risk factors and cardiovascular morbidity].
    Reindel J; Zander E; Heinke P; Kohnert KD; Allwardt C; Kerner W
    Herz; 2004 Aug; 29(5):463-9. PubMed ID: 15340731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study.
    de Ritter R; Sep SJS; van der Kallen CJH; Schram MT; Koster A; Kroon AA; van Greevenbroek MMJ; Eussen SJPM; Dagnelie PC; de Jong M; Vos RC; Woodward M; Bots ML; Peters SAE; Stehouwer CDA
    BMJ Open Diabetes Res Care; 2019; 7(1):e000787. PubMed ID: 31798903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.